4th International Conference on
Innovations and Advances in Cancer Research and Treatment
October 08–09, 2026 | Tokyo, Japan
CPD
ANA Crowne Plaza Narita
Address: 68 Horinouchi, Narita, Chiba 286-0107, Japan
Phone: +44 2045874848
WhatsApp: +44 7429481517

Cancer Biomarkers & Companion Diagnostics

Cancer Biomarkers & Companion Diagnostics

Cancer Biomarkers & Companion Diagnostics emphasizes the discovery, validation, and clinical application of biomarkers that support early detection, prognosis, treatment selection, and therapeutic monitoring. Companion diagnostics play a vital role in precision oncology by identifying patients most likely to benefit from targeted therapies and immunotherapies. This session welcomes research on molecular biomarkers, genomic profiling, predictive and prognostic markers, biomarker-driven clinical decision-making, and emerging diagnostic technologies that advance personalized cancer treatment.

  • Predictive Biomarkers
  • Companion Diagnostics
  • Molecular Profiling
  • Precision Oncology
  • Prognostic Biomarkers
  • Personalized Cancer Therapy

Related Sessions